| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.DRUDIS.2009.06.009 |
| P698 | PubMed publication ID | 19576998 |
| P50 | author | Frank Kooy | Q37843120 |
| John Atack | Q63352032 | ||
| P2093 | author name string | Charlotte D'Hulst | |
| P433 | issue | 17-18 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 866-875 | |
| P577 | publication date | 2009-07-02 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | The complexity of the GABAA receptor shapes unique pharmacological profiles | |
| P478 | volume | 14 |
| Q44896303 | 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease. |
| Q47806761 | Allopregnanolone involvement in feeding regulation, overeating and obesity |
| Q57173780 | An Emerging Circuit Pharmacology of GABA Receptors |
| Q50344832 | Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus |
| Q34309971 | Benzodiazepine dependence and its treatment with low dose flumazenil. |
| Q36252609 | Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of α1 GABA(A) receptors |
| Q37603440 | Benzodiazepine-like discriminative stimulus effects of toluene vapor |
| Q58853545 | Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase |
| Q37780606 | Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective |
| Q35418044 | Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model |
| Q51866152 | Developmental expression and distribution of GABA(A) receptor α1-, α3- and β2-subunits in pig brain. |
| Q41628434 | Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones |
| Q42957784 | Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression |
| Q36410331 | Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors |
| Q34260110 | Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity |
| Q33942739 | Editing of neurotransmitter receptor and ion channel RNAs in the nervous system |
| Q48309787 | Effects of diazepam on BOLD activation during the processing of aversive faces |
| Q48516000 | Effects of neonatal exposure to the flame retardant tetrabromobisphenol-A, aluminum diethylphosphinate or zinc stannate on long-term potentiation and synaptic protein levels in mice |
| Q39784438 | Effects of the benzodiazepine GABAA α1-preferring ligand, 3-propoxy-β-carboline hydrochloride (3-PBC), on alcohol seeking and self-administration in baboons |
| Q30584510 | Efficient modulation of γ-aminobutyric acid type A receptors by piperine derivatives |
| Q37855928 | Evolving therapeutic indications for N-type calcium channel blockers: from chronic pain to alcohol abuse |
| Q37965230 | GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam |
| Q86521044 | GABAA Receptors of Cerebellar Granule Cells in Culture: Interaction with Benzodiazepines |
| Q38175971 | GABAergic dysfunction in pediatric neuro-developmental disorders |
| Q34689960 | Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models |
| Q24631269 | How addictive drugs disrupt presynaptic dopamine neurotransmission |
| Q38653220 | Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities |
| Q45134796 | Inhibitory effects of insulin on GABAA currents modulated by the GABAA alpha subunit |
| Q35160645 | Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors. |
| Q34809169 | Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy |
| Q26740518 | Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids |
| Q54977843 | Mitochondrial dysfunction in an animal model of diabetic neuropathy is associated with a reduction of neurosteroid synthesis. |
| Q35134568 | MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity |
| Q92940436 | Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences |
| Q38107890 | Modulation of cell viability, oxidative stress, calcium homeostasis, and voltage- and ligand-gated ion channels as common mechanisms of action of (mixtures of) non-dioxin-like polychlorinated biphenyls and polybrominated diphenyl ethers. |
| Q37693559 | Neurosteroids are reduced in diabetic neuropathy and may be associated with the development of neuropathic pain. |
| Q38137691 | Neurotranmission systems as targets for toxicants: a review |
| Q37285432 | Novel ncRNAs transcribed by Pol III and elucidation of their functional relevance by biophysical approaches |
| Q34221937 | Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review |
| Q37978338 | Paradoxical and bidirectional drug effects |
| Q90633512 | Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) acutely affect human α1β2γ2L GABAA receptor and spontaneous neuronal network function in vitro |
| Q41831739 | Perisynaptic GABA Receptors The Overzealous Protector. |
| Q35177102 | Pharmacological characterisation of murine α4β1δ GABAA receptors expressed in Xenopus oocytes |
| Q45329351 | Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites |
| Q28083673 | Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination |
| Q34678100 | Retrochalcone derivatives are positive allosteric modulators at synaptic and extrasynaptic GABA(A) receptors in vitro |
| Q24606813 | Social influences on neurobiology and behavior: epigenetic effects during development |
| Q33624375 | State-dependent plasticity of the corticostriatal pathway |
| Q26745117 | Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome |
| Q37203454 | Synergistic and compensatory effects of two point mutations conferring target-site resistance to fipronil in the insect GABA receptor RDL. |
| Q41825505 | Testing the silence of mutations: Transcriptomic and behavioral studies of GABA(A) receptor α1 and α2 subunit knock-in mice. |
| Q37937459 | The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy |
| Q34123254 | Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats |
| Q34131906 | Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization |
| Q38687615 | Withdrawing Benzodiazepines in Patients With Anxiety Disorders |
Search more.